Rights and permissions
About this article
Cite this article
Chronic respiratory conditions incur substantial cost in the US. Pharmacoecon. Outcomes News 362, 9 (2002). https://doi.org/10.1007/BF03279056
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279056